Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder

PHASE3CompletedINTERVENTIONAL

Enrollment

247

Participants

Timeline

Start Date

Not specified

Primary Completion Date

May 31, 2004

Study Completion Date

May 31, 2004

Conditions

Major Depressive Disorder

Interventions

DRUG

DVS-233 SR

All Listed Sponsors

lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00063206 - Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder | Biotech Hunter | Biotech Hunter